Vimizim Interactions
No drug interactions were found for Vimizim (elosulfase alfa). However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Vimizim (elosulfase alfa) is in the drug class lysosomal enzymes. Vimizim (elosulfase alfa) is used for Mucopolysaccharidosis Type IV.
Vimizim disease interactions
There is 1 disease interaction with Vimizim (elosulfase alfa) which include:
More about Vimizim (elosulfase alfa)
- Vimizim consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Aldurazyme
Aldurazyme is used to treat the symptoms of Hurler syndrome. Learn about side effects, interactions ...
Brineura
Brineura (cerliponase alfa) is used to slow the loss of ability to crawl or walk in children and ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Cerezyme
Cerezyme is a man-made form of an enzyme that occurs naturally in the body. It is used as an enzyme ...
Elaprase
Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called ...
Elelyso
Elelyso (taliglucerase alfa) is used to treat Gaucher disease. Includes Elelyso side effects ...
Elfabrio
Elfabrio (pegunigalsidase alfa-iwxj) is an enzyme replacement treatment that may be used long-term ...
Fabrazyme
Fabrazyme (agalsidase beta) is used in the treatment of Fabry disease. Includes Fabrazyme side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.